Research Article

Combination of Xuesaitong and Aspirin Based on the Antiplatelet Effect and Gastrointestinal Injury: Study Protocol for a Randomized Controlled Noninferiority Trial

Table 3

Dose and duration of medication.

GroupMedicationDose and methodDuration

Aspirin groupEnteric-coated aspirin100 mg, q.d., oral30 days
Xuesaitong groupXuesaitong soft capsule200 mg, t.i.d., oral30 days
Drug combination groupXuesaitong soft capsule + enteric-coated aspirin100 mg q.d. oral aspirin and 200 mg t.i.d. oral Xuesaitong soft capsule30 days